Cargando…
Venous Thromboembolism in Patients with Cancer Receiving Specialist Palliative Care
CONTEXT: The prevalence of venous thromboembolism (VTE) in patients with cancer is particularly high at disease progression and during relapse. Patients cared for in specialized palliative care units (SPCU) are rarely included in VTE studies. Objective: We sought to study the prevalence, clinical ch...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8894932/ https://www.ncbi.nlm.nih.gov/pubmed/35225029 http://dx.doi.org/10.1177/10760296221081121 |
_version_ | 1784662796670074880 |
---|---|
author | Allende-Pérez, Silvia Rosa Cesarman-Maus, Gabriela Peña-Nieves, Adriana Arcos, Amelia Baz-Gutiérrez, Patricia Robles, Joanna LeBlanc, Thomas W. |
author_facet | Allende-Pérez, Silvia Rosa Cesarman-Maus, Gabriela Peña-Nieves, Adriana Arcos, Amelia Baz-Gutiérrez, Patricia Robles, Joanna LeBlanc, Thomas W. |
author_sort | Allende-Pérez, Silvia Rosa |
collection | PubMed |
description | CONTEXT: The prevalence of venous thromboembolism (VTE) in patients with cancer is particularly high at disease progression and during relapse. Patients cared for in specialized palliative care units (SPCU) are rarely included in VTE studies. Objective: We sought to study the prevalence, clinical characteristics, and survival of individuals with VTE in an SPCU setting. METHODS: We retrospectively included 2707 consecutive individuals with active cancer managed at a SPCU. Data were summarized using descriptive statistics and frequency for categorical variables. Overall survival was estimated by Kaplan-Meier and comparisons by log-rank test. Thrombotic events were confirmed by imaging. RESULTS: We studied 1984(73.3%) women and 723 (26.7%) men. The overall prevalence of thrombosis was 22.2% with only 6.2% occurring after initiating SPCU care, and was higher in women (24.6% vs 15.8%), particularly with gynecological tumors (cervical: 30.5%, ovarian: 29.2%). Median survival was slightly longer for patients without VTE (80 days [IQR21-334] and 69 days [IQR 25-235]; p = 0.03). CONCLUSIONS: Prevalence of VTE was high and varied by tumor origin. VTE may impact survival. Though median survival is short, some patients are followed over months, suggesting that in the absence of high bleeding risk, treatment for thrombosis in an attempt to decrease the morbidity of re-thrombosis should be considered. On the other hand, few patients developed symptomatic VTE during SPCU care, making generalized primary prophylaxis probably unwarranted. Customizing anticoagulation for the risk of hemorrhage and physical performance is essential. |
format | Online Article Text |
id | pubmed-8894932 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | SAGE Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-88949322022-03-05 Venous Thromboembolism in Patients with Cancer Receiving Specialist Palliative Care Allende-Pérez, Silvia Rosa Cesarman-Maus, Gabriela Peña-Nieves, Adriana Arcos, Amelia Baz-Gutiérrez, Patricia Robles, Joanna LeBlanc, Thomas W. Clin Appl Thromb Hemost Original Manuscript CONTEXT: The prevalence of venous thromboembolism (VTE) in patients with cancer is particularly high at disease progression and during relapse. Patients cared for in specialized palliative care units (SPCU) are rarely included in VTE studies. Objective: We sought to study the prevalence, clinical characteristics, and survival of individuals with VTE in an SPCU setting. METHODS: We retrospectively included 2707 consecutive individuals with active cancer managed at a SPCU. Data were summarized using descriptive statistics and frequency for categorical variables. Overall survival was estimated by Kaplan-Meier and comparisons by log-rank test. Thrombotic events were confirmed by imaging. RESULTS: We studied 1984(73.3%) women and 723 (26.7%) men. The overall prevalence of thrombosis was 22.2% with only 6.2% occurring after initiating SPCU care, and was higher in women (24.6% vs 15.8%), particularly with gynecological tumors (cervical: 30.5%, ovarian: 29.2%). Median survival was slightly longer for patients without VTE (80 days [IQR21-334] and 69 days [IQR 25-235]; p = 0.03). CONCLUSIONS: Prevalence of VTE was high and varied by tumor origin. VTE may impact survival. Though median survival is short, some patients are followed over months, suggesting that in the absence of high bleeding risk, treatment for thrombosis in an attempt to decrease the morbidity of re-thrombosis should be considered. On the other hand, few patients developed symptomatic VTE during SPCU care, making generalized primary prophylaxis probably unwarranted. Customizing anticoagulation for the risk of hemorrhage and physical performance is essential. SAGE Publications 2022-02-28 /pmc/articles/PMC8894932/ /pubmed/35225029 http://dx.doi.org/10.1177/10760296221081121 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access page (https://us.sagepub.com/en-us/nam/open-access-at-sage). |
spellingShingle | Original Manuscript Allende-Pérez, Silvia Rosa Cesarman-Maus, Gabriela Peña-Nieves, Adriana Arcos, Amelia Baz-Gutiérrez, Patricia Robles, Joanna LeBlanc, Thomas W. Venous Thromboembolism in Patients with Cancer Receiving Specialist Palliative Care |
title | Venous Thromboembolism in Patients with Cancer Receiving Specialist Palliative Care |
title_full | Venous Thromboembolism in Patients with Cancer Receiving Specialist Palliative Care |
title_fullStr | Venous Thromboembolism in Patients with Cancer Receiving Specialist Palliative Care |
title_full_unstemmed | Venous Thromboembolism in Patients with Cancer Receiving Specialist Palliative Care |
title_short | Venous Thromboembolism in Patients with Cancer Receiving Specialist Palliative Care |
title_sort | venous thromboembolism in patients with cancer receiving specialist palliative care |
topic | Original Manuscript |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8894932/ https://www.ncbi.nlm.nih.gov/pubmed/35225029 http://dx.doi.org/10.1177/10760296221081121 |
work_keys_str_mv | AT allendeperezsilviarosa venousthromboembolisminpatientswithcancerreceivingspecialistpalliativecare AT cesarmanmausgabriela venousthromboembolisminpatientswithcancerreceivingspecialistpalliativecare AT penanievesadriana venousthromboembolisminpatientswithcancerreceivingspecialistpalliativecare AT arcosamelia venousthromboembolisminpatientswithcancerreceivingspecialistpalliativecare AT bazgutierrezpatricia venousthromboembolisminpatientswithcancerreceivingspecialistpalliativecare AT roblesjoanna venousthromboembolisminpatientswithcancerreceivingspecialistpalliativecare AT leblancthomasw venousthromboembolisminpatientswithcancerreceivingspecialistpalliativecare |